Testmate Health and Intermountain Health have entered a strategic collaboration and investment agreement to expedite the accessibility of rapid, molecular sexually transmitted infections (STIs) tests in the US.
The partnership aims to deliver laboratory-quality diagnostics for these infections to communities at risk.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
These infections continue to pose a challenge, with an estimated 80% of chlamydia and gonorrhoea cases remaining undiagnosed every year.
The alliance seeks to make low-cost, high-accuracy diagnostic solutions widely accessible, particularly for individuals and locations with the greatest need.
Intermountain Health Lab Services vice-president Karen Brownwell said: “Our partnership and investment in Testmate reflects our commitment to solutions that make care faster, more accessible, and equitable.
“When these STI tests become Food and Drug Administration (FDA)-approved in the US, Testmate’s innovative approach to molecular diagnostics will allow us to deliver lab-quality results outside traditional lab settings, directly impacting communities that have historically lacked access to timely testing.”
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataTestmate’s single-use molecular test for Chlamydia trachomatis and Neisseria gonorrhoeae does not require a reader and claims to provide laboratory-quality results in less than 30 minutes, without the need for central laboratory facilities.
The tests are designed for ease of use and accept both urine and swab samples, allowing for discreet and private testing experiences.
Testmate Health founder and CEO Dr Siew-Veena Sahi said: “This partnership and investment empowers people to take control of their sexual and reproductive health without barriers, stigma, or waiting.
“By partnering with Intermountain Health, we could scale access to diagnostics in a way that changes outcomes for patients and communities alike.”
Testmate Health is focused on advancing affordable, high-precision molecular diagnostics for sexual and women’s health.
Based in the US, Intermountain Health operates as a nonprofit network comprising 34 hospitals, around 400 clinics, and medical groups.
